Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment - A case report and review of literature

Jun Inaishi, Shigeru Nogawa, Yoshinori Mano, Takahito Yoshizaki, Satoshi Okada

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A 72-year-old male with heart failure was admitted to our hospital. Treatment with dabigatran (220 mg per day) was initiated because of atrial fibrillation. On the third day, the patient developed left-sided hemiparesis and dysarthria at 4.5 hr after the last dose of dabigatran. The activated partial thromboplastin time (APTT) was 39.1 sec, and the NIHSS (NIH Stroke Scale) was 11. An intravenous infusion of rt-PA was administered at 160 min after the onset of hemiparesis (at 7 hr after the last dose of dabigatran). Although diffusion weighted MRI revealed a minor infarction in the right lower frontal gyrus, the patient was discharged without hemorrhage (NIHSS 0), and the score on the modified Rankin scale assessed 3 months later was 0. The outcomes have been good in 8 out of 9 reported cases, including the present case; the remaining severe case developed complicating intracranial hemorrhage. Thrombolytic therapy could be safe, if it is performed more than 7 hr after the last dose of dabigatran and the APTT is less than 40 sec.

Original languageEnglish
Pages (from-to)238-240
Number of pages3
JournalClinical Neurology
Volume54
Issue number3
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Stroke
Hemorrhage
Partial Thromboplastin Time
Paresis
Dysarthria
Diffusion Magnetic Resonance Imaging
Intracranial Hemorrhages
Thrombolytic Therapy
Therapeutics
Intravenous Infusions
Atrial Fibrillation
Infarction
Heart Failure
Dabigatran

Keywords

  • Alteplase
  • Cardioembolic stroke
  • Dabigatran
  • Novel oral anticoalgulants
  • Rt-PA

ASJC Scopus subject areas

  • Clinical Neurology
  • Medicine(all)

Cite this

Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment - A case report and review of literature. / Inaishi, Jun; Nogawa, Shigeru; Mano, Yoshinori; Yoshizaki, Takahito; Okada, Satoshi.

In: Clinical Neurology, Vol. 54, No. 3, 01.01.2014, p. 238-240.

Research output: Contribution to journalArticle

@article{8aa2c8fd42a945c995d4e28fd0c95644,
title = "Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment - A case report and review of literature",
abstract = "A 72-year-old male with heart failure was admitted to our hospital. Treatment with dabigatran (220 mg per day) was initiated because of atrial fibrillation. On the third day, the patient developed left-sided hemiparesis and dysarthria at 4.5 hr after the last dose of dabigatran. The activated partial thromboplastin time (APTT) was 39.1 sec, and the NIHSS (NIH Stroke Scale) was 11. An intravenous infusion of rt-PA was administered at 160 min after the onset of hemiparesis (at 7 hr after the last dose of dabigatran). Although diffusion weighted MRI revealed a minor infarction in the right lower frontal gyrus, the patient was discharged without hemorrhage (NIHSS 0), and the score on the modified Rankin scale assessed 3 months later was 0. The outcomes have been good in 8 out of 9 reported cases, including the present case; the remaining severe case developed complicating intracranial hemorrhage. Thrombolytic therapy could be safe, if it is performed more than 7 hr after the last dose of dabigatran and the APTT is less than 40 sec.",
keywords = "Alteplase, Cardioembolic stroke, Dabigatran, Novel oral anticoalgulants, Rt-PA",
author = "Jun Inaishi and Shigeru Nogawa and Yoshinori Mano and Takahito Yoshizaki and Satoshi Okada",
year = "2014",
month = "1",
day = "1",
doi = "10.5692/clinicalneurol.54.238",
language = "English",
volume = "54",
pages = "238--240",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "3",

}

TY - JOUR

T1 - Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment - A case report and review of literature

AU - Inaishi, Jun

AU - Nogawa, Shigeru

AU - Mano, Yoshinori

AU - Yoshizaki, Takahito

AU - Okada, Satoshi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A 72-year-old male with heart failure was admitted to our hospital. Treatment with dabigatran (220 mg per day) was initiated because of atrial fibrillation. On the third day, the patient developed left-sided hemiparesis and dysarthria at 4.5 hr after the last dose of dabigatran. The activated partial thromboplastin time (APTT) was 39.1 sec, and the NIHSS (NIH Stroke Scale) was 11. An intravenous infusion of rt-PA was administered at 160 min after the onset of hemiparesis (at 7 hr after the last dose of dabigatran). Although diffusion weighted MRI revealed a minor infarction in the right lower frontal gyrus, the patient was discharged without hemorrhage (NIHSS 0), and the score on the modified Rankin scale assessed 3 months later was 0. The outcomes have been good in 8 out of 9 reported cases, including the present case; the remaining severe case developed complicating intracranial hemorrhage. Thrombolytic therapy could be safe, if it is performed more than 7 hr after the last dose of dabigatran and the APTT is less than 40 sec.

AB - A 72-year-old male with heart failure was admitted to our hospital. Treatment with dabigatran (220 mg per day) was initiated because of atrial fibrillation. On the third day, the patient developed left-sided hemiparesis and dysarthria at 4.5 hr after the last dose of dabigatran. The activated partial thromboplastin time (APTT) was 39.1 sec, and the NIHSS (NIH Stroke Scale) was 11. An intravenous infusion of rt-PA was administered at 160 min after the onset of hemiparesis (at 7 hr after the last dose of dabigatran). Although diffusion weighted MRI revealed a minor infarction in the right lower frontal gyrus, the patient was discharged without hemorrhage (NIHSS 0), and the score on the modified Rankin scale assessed 3 months later was 0. The outcomes have been good in 8 out of 9 reported cases, including the present case; the remaining severe case developed complicating intracranial hemorrhage. Thrombolytic therapy could be safe, if it is performed more than 7 hr after the last dose of dabigatran and the APTT is less than 40 sec.

KW - Alteplase

KW - Cardioembolic stroke

KW - Dabigatran

KW - Novel oral anticoalgulants

KW - Rt-PA

UR - http://www.scopus.com/inward/record.url?scp=84896528346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896528346&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.54.238

DO - 10.5692/clinicalneurol.54.238

M3 - Article

VL - 54

SP - 238

EP - 240

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 3

ER -